We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1151
DELISTED
Veradigm Inc. Common Stock
MDRX
| $2.91M | 0.01% |
243,149
+12,740
| +6% | +$156K |
|
1152
Opko Health
OPK
$985M
| $2.9M | 0.01% |
205,035
+30,650
| +18% | +$399K |
|
1153
Cimpress
CMPR
$2.49B
| $2.9M | 0.01% |
34,403
+4,890
| +17% | +$391K |
|
|
KNGT
1154
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $2.9M | 0.01% |
89,916
+2,240
| +3% | +$72.2K |
|
1155
Buckle
BKE
$2.36B
| $2.9M | 0.01% |
56,668
+18,795
| +50% | +$946K |
|
1156
J&J Snack Foods
JJSF
$1.55B
| $2.9M | 0.01% |
27,130
+1,563
| +6% | +$163K |
|
1157
Delek US
DK
$3.73B
| $2.89M | 0.01% |
72,805
+5,500
| +8% | +$182K |
|
|
NRF
1158
DELISTED
NorthStar Realty Finance Corp.
NRF
| $2.89M | 0.01% |
79,806
+15,820
| +25% | +$586K |
|
1159
Mine Safety
MSA
$7.52B
| $2.88M | 0.01% |
57,767
+6,292
| +12% | +$304K |
|
1160
Targa Resources
TRGP
$55.9B
| $2.87M | 0.01% |
29,989
+1,760
| +6% | +$165K |
|
|
SYA
1161
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $2.87M | 0.01% |
122,457
+25,125
| +26% | +$562K |
|
|
ALR
1162
DELISTED
Alere Inc
ALR
| $2.87M | 0.01% |
58,693
-150
| -0.3% | -$6.58K |
|
|
KND
1163
DELISTED
Kindred Healthcare
KND
| $2.87M | 0.01% |
120,512
+13,217
| +12% | +$268K |
|
1164
Visteon
VC
$2.78B
| $2.86M | 0.01% |
29,691
-128
| -0.4% | -$12.8K |
|
1165
Oil States International
OIS
$498M
| $2.86M | 0.01% |
71,929
+2,118
| +3% | +$89.6K |
|
1166
Molina Healthcare
MOH
$10.2B
| $2.85M | 0.01% |
42,401
+6,415
| +18% | +$371K |
|
1167
KBR
KBR
$4.6B
| $2.85M | 0.01% |
196,957
+10,762
| +6% | +$175K |
|
|
DFT
1168
DELISTED
DuPont Fabros Technology Inc.
DFT
| $2.85M | 0.01% |
87,247
+3,255
| +4% | +$110K |
|
1169
Celldex Therapeutics
CLDX
$3.13B
| $2.85M | 0.01% |
6,806
+868
| +15% | +$311K |
|
|
ROIC
1170
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $2.84M | 0.01% |
155,405
+2,450
| +2% | +$43K |
|
1171
Sprouts Farmers Market
SFM
$7.96B
| $2.84M | 0.01% |
80,665
+4,240
| +6% | +$150K |
|
1172
IQVIA
IQV
$38.9B
| $2.84M | 0.01% |
42,417
+1,170
| +3% | +$73.8K |
|
1173
Granite Construction
GVA
$5.46B
| $2.84M | 0.01% |
80,755
+4,060
| +5% | +$141K |
|
1174
MGE Energy Inc
MGEE
$2.99B
| $2.83M | 0.01% |
63,975
-9,127
| -12% | -$405K |
|
1175
Community Bank
CBU
$3.48B
| $2.83M | 0.01% |
79,855
-450
| -0.6% | -$15.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.